Masashi Kawamura

Dr. Masashi Kawamura

Sendai City Hospital, Sendai, Miyagi, Japan
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2003 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
MKMasashi Kawamura
Masashi Kawamura
SOS Ohara
S Ohara
TKT Koike
T Koike
KIK Iijima
K Iijima
JSJ Suzuki
J Suzuki
SGStudy Group of GERD
Study Group of GERD

20 August 2021 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
MKMasashi Kawamura
Masashi Kawamura
NUNoriya Uedo
Noriya Uedo
TKTomoyuki Koike
Tomoyuki Koike
TKTakashi Kanesaka
Takashi Kanesaka
WHWaku Hatta
Waku Hatta
TSToshio Shimokawa
Toshio Shimokawa

17 February 2011 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MKMasashi Kawamura
Masashi Kawamura
SAShu Abe
Shu Abe
KOKeisuke Oikawa
Keisuke Oikawa
STShiho Terai
Shiho Terai
MSMasahiro Saito
Masahiro Saito
TMTakayuki Masuda
Takayuki Masuda

29 January 2007 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MKMasashi Kawamura
Masashi Kawamura
SOShuichi Ohara
Shuichi Ohara
TKTomoyuki Koike
Tomoyuki Koike
KIKatsunori Iijima
Katsunori Iijima
HSHitoshi Suzuki
Hitoshi Suzuki
TSToru Shimosegawa
Toru Shimosegawa

13 May 2024 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MKMasashi Kawamura
Masashi Kawamura
NUNoriya Uedo
Noriya Uedo
KYKenshi Yao
Kenshi Yao
TKTomoyuki Koike
Tomoyuki Koike
TKTakashi Kanesaka
Takashi Kanesaka
TKTakao Kanemitsu
Takao Kanemitsu

1 July 1992 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
HIHisao Itoh
Hisao Itoh
TSToyohiko Sakai
Toyohiko Sakai
NTNorio Takahashi
Norio Takahashi
MKMasahisa Kitada
Masahisa Kitada
MSMasayuki Saito
Masayuki Saito
MKMasashi Kawamura
Masashi Kawamura
The frequency and degree of periportal high intensity (PHI) on T2-weighted images in 28 patients (32 MR studies) with acute viral hepatitis were analyzed with regard to the various levels of serum glutamic-oxaloacetic transaminase (SGOT) and clinical phases. Periportal high intensity was found in 16 of 32 MR studies (50%) and no definite PHI was found in 7 studies (22%). Periportal high intensity appeared when the SGOT level was >500 IU or when the phase of the disease was early. Follow-up studies revealed that PHI decreased during clinical recovery. We conclude that the degree of PHI on T2-weighted images reflects the severity of the disease in acute viral hepatitis.